# US Veterinary CBD Market

> United States Veterinary CBD Market Research Report: Size, Share, Trend Analysis - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.75%
- **2024:** $ 182.92 Million
- **2025:** $ 196.61 Million
- **2035:** $ 338.25 Million
- **Key Players:** Pet Releaf (US), Canna-Pet (US), HolistaPet (US), King Kanine (US), Charlotte's Web (US), MediPets (US), Paw CBD (US), CBD Dog Health (US)

**Report ID:** MRFR/HC/11927-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-veterinary-cbd-market-13452

---

## Market Summary

## US Veterinary CBD Market Highlighted Trends & Dynamics

The US Veterinary CBD Market: A Pawsome Panorama of Potential

The burgeoning US pet care industry has witnessed a curious convergence with the rising tide of cannabidiol (CBD) popularity. This unlikely pairing has given birth to the US veterinary CBD market, a space teeming with promise and complexities in equal measure. Examining this nascent market reveals a landscape sculpted by surging pet ownership, evolving regulations, and a diverse cast of players vying for a slice of the pie.

Pet Parents Paving the Way: A Surge in Demand

The US pet care industry is a behemoth, with pet ownership exceeding 69 million households in 2021. This translates to a nation deeply invested in the well-being of its furry (and feathered, and scaled) companions. Pet owners are increasingly seeking natural alternatives to conventional veterinary treatments, and CBD, a non-psychoactive compound derived from the hemp plant, has emerged as a potential game-changer.

A Spectrum of Potential Applications

Veterinarians are exploring the therapeutic potential of CBD for a range of animal ailments, including:

Pain management: CBD's anti-inflammatory properties may offer relief for conditions like arthritis and hip dysplasia.

Anxiety and stress: Studies suggest CBD can help alleviate anxiety in dogs and cats, potentially aiding with separation anxiety, travel stress, and even noise phobias.

Seizure control: Anecdotal evidence and preliminary research indicate CBD may be beneficial in reducing seizure frequency in epileptic pets.

Appetite stimulation: CBD may help boost appetite in pets suffering from chronic illness or undergoing treatment.

Regulatory Maze: A Patchwork of Progress

The legal landscape surrounding CBD for animals remains a patchwork quilt. While the 2018 Farm Bill legalized hemp-derived CBD at the federal level, its use in veterinary medicine is still largely unregulated. Individual states hold the reins, with some allowing its use under veterinary supervision, while others maintain stricter regulations or outright bans. This regulatory ambiguity creates uncertainty for veterinarians and pet owners alike.

A Menagerie of Players: Established Giants and Nimble Newcomers

The US veterinary CBD market is a motley crew, encompassing established pet care companies, veterinary clinics, and CBD-specific brands. Traditional players like Zoetis and Hill's Pet Nutrition are cautiously dipping their toes into the CBD pool, while smaller, nimble startups like Petly and HolistaPet are carving their own niches with innovative products and targeted marketing.

Challenges and Opportunities: A Balancing Act

Despite its promise, the US veterinary CBD market faces hurdles. Lack of standardized regulations, limited research data, and potential drug interactions are some of the challenges that need to be addressed. However, the market also brims with opportunities. Growing consumer awareness, increasing scientific research, and potential regulatory reforms all point towards a bright future for veterinary CBD.

Looking Ahead: A Tail-Wagging Tomorrow

The US veterinary CBD market is still in its infancy, but its potential is undeniable. As regulations evolve, research expands, and pet owners continue to seek natural wellness solutions, this market is poised for significant growth. The future of veterinary CBD is likely to be a collaborative effort, with veterinarians, pet care companies, and researchers working together to unlock the full potential of this natural remedy for our furry (and feathered, and scaled) friends.

## Market Drivers

### Innovation in Product Development

Innovation within the product development sphere is a key driver for the US Veterinary CBD Market. Companies are increasingly focusing on creating a diverse range of CBD-infused products tailored specifically for pets, including treats, oils, and topical applications. This diversification not only caters to different pet needs but also appeals to a broader consumer base. The introduction of new formulations, such as water-soluble CBD and products designed for specific health issues, indicates a growing understanding of the unique requirements of pets. As manufacturers invest in research and development to enhance product efficacy and safety, the US Veterinary CBD Market is likely to experience robust growth. This emphasis on innovation is essential for meeting the evolving demands of pet owners and ensuring the long-term sustainability of the market.

### Rising Pet Ownership and Spending

The surge in pet ownership across the United States has been a significant factor influencing the US Veterinary CBD Market. According to the American Pet Products Association, approximately 67% of U.S. households own a pet, which translates to around 85 million families. This increase in pet ownership correlates with a rise in spending on pet [health and wellness products](https://www.marketresearchfuture.com/reports/health-and-wellness-product-market-24639), including CBD. Pet owners are increasingly seeking alternative therapies for their pets, particularly for conditions such as anxiety, arthritis, and chronic pain. The willingness to invest in premium health products, including CBD, suggests a growing market potential. As pet owners become more informed about the benefits of CBD, the demand for these products in the US Veterinary CBD Market is expected to escalate, creating opportunities for both established and emerging companies.

### Regulatory Changes Favoring CBD Use

The evolving regulatory landscape surrounding cannabis products in the United States appears to be a pivotal driver for the US Veterinary CBD Market. Recent legislative changes have led to increased acceptance of CBD products for veterinary use, particularly in states where cannabis has been legalized. The 2018 Farm Bill, which legalized hemp-derived CBD, has opened avenues for veterinarians to explore CBD as a treatment option for various ailments in pets. This regulatory shift not only enhances the credibility of CBD products but also encourages manufacturers to invest in research and development, thereby expanding the product offerings in the US Veterinary CBD Market. As regulations continue to evolve, it is likely that more veterinarians will incorporate CBD into their treatment protocols, further driving market growth.

### Increased Focus on Holistic Pet Care

The trend towards holistic pet care is gaining traction in the United States, significantly impacting the US Veterinary CBD Market. Pet owners are increasingly seeking natural and alternative remedies for their pets, moving away from traditional pharmaceuticals that may have adverse side effects. CBD, known for its potential therapeutic benefits, aligns well with this holistic approach. As veterinarians and pet owners alike recognize the value of integrating CBD into treatment plans, the market is likely to see a surge in demand. This shift towards holistic care not only enhances the appeal of CBD products but also encourages manufacturers to develop high-quality, organic options that cater to health-conscious consumers. The growing emphasis on holistic pet care is expected to drive innovation and expansion within the US Veterinary CBD Market.

### Consumer Awareness and Education Initiatives

Consumer awareness regarding the benefits of CBD for pets is on the rise, which is a crucial driver for the US Veterinary CBD Market. Educational initiatives by veterinarians, pet organizations, and manufacturers are playing a vital role in informing pet owners about the potential advantages of CBD. As more studies emerge highlighting the efficacy of CBD in treating various conditions in animals, pet owners are becoming more inclined to consider these products. This increased awareness is likely to lead to higher adoption rates of CBD among pet owners, thereby expanding the market. Furthermore, as veterinarians become more knowledgeable about CBD, they are more likely to recommend it as a viable treatment option, further solidifying its place in the US Veterinary CBD Market.

## Future Outlook

The US Veterinary CBD Market is projected to grow at a 5.75% CAGR from 2025 to 2035, driven by increasing pet health awareness and regulatory advancements.

**New opportunities:**

- Development of specialized CBD formulations for specific pet ailments.
- Expansion of e-commerce platforms for direct-to-consumer sales.
- Partnerships with veterinary clinics for integrated CBD treatment plans.

By 2035, the market is expected to solidify its position as a key player in pet healthcare.

## Segment Insights

### By Source: Hemp-Derived (Largest) vs. Marijuana-Derived (Fastest-Growing)

In the US veterinary cbd market, the source segment exhibits a diverse distribution with hemp-derived products holding the largest market share. This dominance is attributed to the widespread acceptance of hemp-based formulations among pet owners and the gentler regulatory environment surrounding hemp compared to marijuana. On the other hand, marijuana-derived products, while holding a smaller share, have gained traction due to their potential therapeutic benefits, appealing to a niche segment of consumers.

Hemp-Derived (Dominant) vs. Marijuana-Derived (Emerging)

Hemp-derived products are predominant in the US veterinary cbd market due to their legality and familiarity among consumers. These products are often marketed for their health benefits without the psychoactive effects characteristic of their marijuana-derived counterparts. Conversely, marijuana-derived products, though emerging, are rapidly gaining attention as they are perceived to offer potent therapeutic effects that may not be available in hemp-derived formulations. These variations cater to different consumer preferences, creating a dynamic interplay within the market as both segments evolve.

### By Products: Therapeutic-Grade (Largest) vs. Personal Care (Fastest-Growing)

In the US veterinary cbd market, the distribution among product segments reveals that Therapeutic-Grade products hold the largest share due to their widespread acceptance among veterinarians and pet owners. Food-Grade products are also significant, catering to the dietary needs of pets, while Personal Care products are emerging quickly, meeting the demand for topical and grooming solutions.

Growth trends in this segment are driven by increasing awareness of the benefits of cbd for various health conditions in pets, leading to higher sales of Therapeutic-Grade options. Meanwhile, the rise in demand for natural grooming products presents a substantial opportunity for Personal Care items, establishing them as the fastest-growing segment as pet owners prioritize wellness and holistic care.

Therapeutic-Grade (Dominant) vs. Personal Care (Emerging)

Therapeutic-Grade products are characterized by their extensive research and formulation to address specific health issues in pets, resulting in a strong foothold in the market. These products are commonly endorsed by veterinarians for their efficacy in treating anxiety, pain, and other ailments. On the other hand, Personal Care products are quickly gaining traction as consumers increasingly seek natural and organic products for grooming and skin care. This segment is particularly attractive to pet owners who prioritize overall pet wellness, and its rapid growth is expected to continue as trends towards holistic pet care gain momentum.

### By Distribution Channel: E-Commerce (Largest) vs. Retail Pharmacies (Fastest-Growing)

The US veterinary cbd market exhibits a diverse distribution channel landscape, with E-Commerce emerging as the largest segment, capturing significant market share due to the convenience and accessibility it offers. Retail Pharmacies, on the other hand, while being the traditional choice, continue to hold a notable portion but face competition from online platforms.

Growth prospects in the distribution channel segment are influenced by the increasing acceptance of CBD products among pet owners and the rising trend of online shopping. This shift is further propelled by the proliferation of digital marketing strategies and improved delivery services. Retail Pharmacies are adapting by enhancing their online presence to remain competitive in this rapidly changing market environment.

E-Commerce: Dominant vs. Retail Pharmacies: Emerging

E-Commerce has established itself as the dominant distribution channel in the US veterinary cbd market, favored for its ease of access, wide range of product offerings, and the ability to cater to consumer preferences for home delivery. This channel attracts a larger customer base, particularly tech-savvy pet owners who prioritize convenience. Conversely, Retail Pharmacies, although classified as emerging within this segment, are adapting to market demands by integrating online sales options and expanding their product selections. Their traditional in-store presence remains vital, as many pet owners appreciate the personalized advice from pharmacists, creating a hybrid model that marries convenience with expert guidance.

### By Distribution Channel: Veterinary Clinics (Largest) vs. Online Retailers (Fastest-Growing)

In the US Veterinary CBD market, the distribution share is primarily dominated by Veterinary Clinics, which hold a significant portion of market access due to trusted professional recommendations. Following closely are Pet Stores and Pharmacies, which cater to general consumers seeking CBD products for their pets, while Online Retailers have shown increasing trends in consumer purchasing behavior. Direct Sales have a modest share, often relying on localized markets and community engagements.

Veterinary Clinics (Dominant) vs. Online Retailers (Emerging)

Veterinary Clinics represent the dominant distribution channel in the US Veterinary CBD market, leveraging the credibility of veterinary professionals to influence pet owners' choices regarding CBD products. Their established patient relationships and advisory capacity contribute significantly to brand loyalty among consumers. On the other hand, Online Retailers are emerging rapidly, driven by convenience and a growing trend of e-commerce among pet owners, especially post-pandemic. This shift towards online shopping reflects a demand for ease of access to a wider range of products, often supported by user reviews and substantial marketing efforts. This dynamic creates a competitive landscape where both channels can thrive by adapting to consumer preferences.

## Competitive Benchmarking

The Veterinary Cbd Market in the US is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding the therapeutic benefits of CBD for pets. Key players such as Pet Releaf (US), Canna-Pet (US), and HolistaPet (US) are strategically positioning themselves through innovation and product diversification. Pet Releaf (US) focuses on organic, full-spectrum CBD products, emphasizing transparency and quality, which resonates with health-conscious pet owners. Canna-Pet (US) has carved a niche by offering a wide range of CBD-infused products tailored for various pet needs, while HolistaPet (US) emphasizes holistic health solutions, integrating CBD with other natural ingredients. Collectively, these strategies foster a competitive environment that prioritizes quality and consumer trust.

In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce costs. The market appears moderately fragmented, with numerous players vying for market share, yet the influence of major companies is palpable. This competitive structure allows for innovation and differentiation, as smaller firms often adopt unique approaches to capture niche segments, while larger entities leverage their resources for broader market penetration.

In December 2025, Pet Releaf (US) announced a partnership with a leading veterinary school to conduct [clinical trials](https://www.marketresearchfuture.com/reports/clinical-trials-market-7787) on the efficacy of their CBD products for treating anxiety in dogs. This strategic move not only enhances their credibility but also positions them as a leader in evidence-based pet care solutions. The collaboration is likely to yield valuable data that could further validate the benefits of CBD, potentially influencing consumer purchasing decisions.

In November 2025, Canna-Pet (US) launched a new line of CBD treats specifically formulated for senior pets, addressing the growing demographic of aging animals. This product expansion reflects a keen understanding of market needs and demonstrates the company's commitment to catering to diverse pet health requirements. By targeting this segment, Canna-Pet (US) may enhance customer loyalty and drive sales growth in a competitive market.

In October 2025, HolistaPet (US) introduced a subscription service for their CBD products, allowing pet owners to receive regular shipments tailored to their pets' needs. This innovative approach not only fosters customer retention but also aligns with the increasing trend of convenience in consumer purchasing behavior. The subscription model could potentially stabilize revenue streams and enhance customer engagement over time.

As of January 2026, the Veterinary Cbd Market is witnessing trends such as digitalization and sustainability, which are reshaping competitive dynamics. Companies are increasingly leveraging technology to enhance customer experiences and streamline operations. Strategic alliances are becoming more prevalent, as firms recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based strategies to a focus on innovation, technology integration, and supply chain reliability, as companies strive to meet the growing demands of discerning pet owners.

## Report Scope

| MARKET SIZE 2024 | 182.92(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 196.61(USD Million) |
| MARKET SIZE 2035 | 338.25(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.75% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Pet Releaf (US), Canna-Pet (US), HolistaPet (US), King Kanine (US), Charlotte's Web (US), MediPets (US), Paw CBD (US), CBD Dog Health (US) |
| Segments Covered | Application, Animal Type, Formulation Type, Distribution Channel |
| Key Market Opportunities | Growing acceptance of Veterinary Cbd products among pet owners presents a lucrative market opportunity. |
| Key Market Dynamics | Growing acceptance of Veterinary CBD products driven by evolving consumer preferences and regulatory advancements in the US. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US veterinary CBD market in 2024?**
A: The market valuation of the US veterinary CBD market was $182.92 Million in 2024.

**Q: What is the projected market valuation for the US veterinary CBD market by 2035?**
A: The projected market valuation for the US veterinary CBD market is $375.0 Million by 2035.

**Q: What is the expected CAGR for the US veterinary CBD market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US veterinary CBD market during the forecast period 2025 - 2035 is 6.74%.

**Q: Which companies are considered key players in the US veterinary CBD market?**
A: Key players in the US veterinary CBD market include Pet Releaf, Canna-Pet, HolistaPet, King Kanine, VetCBD, Paw CBD, CBD Dog Health, and Pure Paws.

**Q: What are the main product segments in the US veterinary CBD market?**
A: The main product segments in the US veterinary CBD market include Therapeutic-Grade, Food-Grade, and Personal Care, with valuations ranging from $36.58 Million to $150.0 Million.

**Q: How does the source of CBD affect market valuation in the US veterinary CBD market?**
A: The source of CBD affects market valuation, with Hemp-Derived products valued at $109.76 Million to $225.0 Million and Marijuana-Derived products at $73.16 Million to $150.0 Million.

**Q: What distribution channels are utilized in the US veterinary CBD market?**
A: Distribution channels in the US veterinary CBD market include Retail Pharmacies, E-Commerce, Vetcare Clinics, and other informal channels, with valuations from $22.92 Million to $150.0 Million.

**Q: What is the valuation range for E-Commerce in the US veterinary CBD market?**
A: The valuation range for E-Commerce in the US veterinary CBD market is between $50.0 Million and $120.0 Million.

**Q: What is the valuation range for Vetcare Clinics in the US veterinary CBD market?**
A: The valuation range for Vetcare Clinics in the US veterinary CBD market is between $80.0 Million and $150.0 Million.

**Q: How do the product segments compare in terms of market valuation?**
A: The product segments compare with Therapeutic-Grade and Food-Grade both valued at $73.17 Million to $150.0 Million, while Personal Care is valued at $36.58 Million to $75.0 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-veterinary-cbd-market-13452*